Literature DB >> 24102953

Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.

A Carlo Altamura1, Massimiliano Buoli, Sara Pozzoli.   

Abstract

Several lines of evidence point to the key role of neurobiological mechanisms and shared genetic background in schizophrenia and bipolar disorder. For both disorders, neurodevelopmental and neurodegenerative processes have been postulated to be relevant for the pathogenesis as well as dysregulation of immuno-inflammatory pathways. Inflammation is a complex biological response to harmful stimuli and it is mediated by cytokines cascades, cellular immune responses, oxidative factors and hormone regulation. Cytokines, in particular, are supposed to play a critical role in infectious and inflammatory processes, mediating the cross-talk between the brain and the immune system; they also possibly contribute to the development of the central nervous system. From this perspective, even though mixed results have been reported, it seems that both schizophrenia and bipolar disorder are associated with an imbalance in inflammatory cytokines; in fact, some of these could represent biological markers of illness and could be possible targets for pharmacological treatments. In light of these considerations, the purpose of the present paper was to provide a comprehensive and critical review of the existing literature about immunological abnormalities in bipolar disorder with particular attention to the similarities and differences with schizophrenia.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  bipolar disorder; immuno-inflammatory system; neurodegenerative hypotheses; neurodevelopment; schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 24102953     DOI: 10.1111/pcn.12089

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  25 in total

1.  Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Ching Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Alcohol Clin Exp Res       Date:  2018-05-17       Impact factor: 3.455

2.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

Review 3.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

4.  Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

Authors:  Kyla A McKay; Helen Tremlett; John D Fisk; Tingting Zhang; Scott B Patten; Lorne Kastrukoff; Trudy Campbell; Ruth Ann Marrie
Journal:  Neurology       Date:  2018-03-09       Impact factor: 9.910

5.  Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway.

Authors:  Clemente Garcia-Rizo; Brian Kirkpatrick; Emilio Fernandez-Egea; Cristina Oliveira; Miquel Bernardo
Journal:  Psychoneuroendocrinology       Date:  2016-02-12       Impact factor: 4.905

6.  6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients.

Authors:  Marco Ferrari; Marco Godio; Camilla Callegari; Marco Cosentino; Franca Marino
Journal:  Psychopharmacol Bull       Date:  2022-05-31

7.  Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein.

Authors:  Daria A Kamaeva; Liudmila P Smirnova; Svetlana N Vasilieva; Daria V Kazantseva; Alisa R Vasilieva; Svetlana A Ivanova
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

8.  Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.

Authors:  Ni Fan; Yayan Luo; Ke Xu; Minling Zhang; Xiaoyin Ke; Xini Huang; Yi Ding; Daping Wang; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Schizophr Res       Date:  2015-11-14       Impact factor: 4.939

9.  Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder.

Authors:  Jinuk Song; Doug Hyun Han; Sun Mi Kim; Ji Sun Hong; Kyung Joon Min; Jae Hoon Cheong; Bung Nyun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-18       Impact factor: 2.570

10.  Does CRP predict outcome in bipolar disorder in regular outpatient care?

Authors:  Sonya M Balukova; Bartholomeus C M Haarman; Rixt F Riemersma-van der Lek; Robert A Schoevers
Journal:  Int J Bipolar Disord       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.